Century Therapeutics, Inc. (IPSC) vs Rocket Pharmaceuticals, Inc. (RCKT)

Century Therapeutics, Inc. and Rocket Pharmaceuticals, Inc. are both Biotechnology companies. Century Therapeutics, Inc. and Rocket Pharmaceuticals, Inc. are of similar size ($306.0M and $300.8M). Across the 11 metrics below, Rocket Pharmaceuticals, Inc. leads on 6 and Century Therapeutics, Inc. on 5.

Valuation

Metric IPSC RCKT Biotechnology median
P/E n/m n/m 7.88
P/S 2.99 n/m 11.47
P/B 1.48 0.80 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 1.95 n/m 10.73
Earnings yield (55.69%) (6.15%) (28.84%)
Free cash flow yield (25.62%) (58.63%) (23.03%)

Profitability

Metric IPSC RCKT Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (49.65%) (4.77%) (57.72%)
Return on assets (38.41%) (4.09%) (49.22%)
Return on invested capital (64.92%) (114.71%) 0.00%

Growth

Metric IPSC RCKT Biotechnology median
Revenue growth (TTM) 8,286.72% — 5.64%
EPS growth (last fiscal year) 93.12% 26.37% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IPSC RCKT Biotechnology median
Debt to equity 0.00 0.05 0.00
Current ratio 8.28 9.24 4.73
Net debt to EBITDA 17.95 0.77 0.96

Dividend

Metric IPSC RCKT Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric IPSC RCKT Biotechnology median
Market cap 306.02m 300.78m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack